HOITT JASON (Chief Patient Officer) sold 26.5% of their position (3.71K shares) of STOKE THERAPEUTICS, INC. on the open market
Open‑market sale worth $119.3K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 3/19/2026ACC: 0001762572-26-000006
Officer· Chief Patient Officer
Since Feb 2026
-3.71K
Net shares
Net seller
$119.3K
Total sold
5
Open market trades
0B · 5S
5
Total transactions
3.71K disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
−1.03K
Price / share
$32.74
Trade value
$33.82K
% of position
7.4%
3/17/2026
13.99K→12.96K
Common Stock
Direct
Shares
−748.00
Price / share
$33.38
Trade value
$24.96K
% of position
5.8%
3/17/2026
12.96K→12.21K
Common Stock
Direct
Shares
−1.76K
Price / share
$31.28
Trade value
$55.12K
% of position
14.4%
3/18/2026
12.21K→10.45K
Common Stock
Direct
Shares
−139.00
Price / share
$31.79
Trade value
$4.42K
% of position
1.3%
3/18/2026
10.45K→10.31K
Common Stock
Direct
Shares
−30.00
Price / share
$32.85
Trade value
$985.50
% of position
0.3%
3/18/2026
10.31K→10.28K
Total
Net shares
−3.71K
Net value
-$119.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2026 | S · Sale | −1.03K | $32.74 | $33.82K | 7.4% | 13.99K | 12.96K |
| Common Stock Direct | 3/17/2026 | S · Sale | −748.00 | $33.38 | $24.96K | 5.8% | 12.96K | 12.21K |
| Common Stock Direct | 3/18/2026 | S · Sale | −1.76K | $31.28 | $55.12K | 14.4% | 12.21K | 10.45K |
| Common Stock Direct | 3/18/2026 | S · Sale | −139.00 | $31.79 | $4.42K | 1.3% | 10.45K | 10.31K |
| Common Stock Direct | 3/18/2026 | S · Sale | −30.00 | $32.85 | $985.50 | 0.3% | 10.31K | 10.28K |
| Total | −3.71K | -$119.31K | ||||||
Derivative Transactions0
No derivative transactions reported